Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms
Background. Currently, during the COVID-19 pandemic, one of the most pressing healthcare problems is to ensure the safety of the population of the Russian Federation. There is insufficient information on the duration and intensity of post-infectious immunity in relation to SARS-CoV-2, especially in...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2020-11-01
|
| Series: | Acta Biomedica Scientifica |
| Subjects: | |
| Online Access: | https://www.actabiomedica.ru/jour/article/view/2436 |
| _version_ | 1797237271002349568 |
|---|---|
| author | S. V. Balakhonov V. I. Dubrovina M. V. Chesnokova V. V. Voitkova A. B. Pyatidesyatnikova D. D. Bryukhova N. O. Kiseleva K. M. Korytov T. G. Kuznetsova Zh. V. Markevich |
| author_facet | S. V. Balakhonov V. I. Dubrovina M. V. Chesnokova V. V. Voitkova A. B. Pyatidesyatnikova D. D. Bryukhova N. O. Kiseleva K. M. Korytov T. G. Kuznetsova Zh. V. Markevich |
| author_sort | S. V. Balakhonov |
| collection | DOAJ |
| description | Background. Currently, during the COVID-19 pandemic, one of the most pressing healthcare problems is to ensure the safety of the population of the Russian Federation. There is insufficient information on the duration and intensity of post-infectious immunity in relation to SARS-CoV-2, especially in case of inapparent (without clinical signs), mild or latent forms of infection.Materials and methods. The study involved 99 volunteers with a laboratory confirmed PCR diagnosis of COVID-19 who were residents of the Irkutsk Region and of other regions of the Russian Federation and arrived to work in Bodaybo on a rotational basis. Also the study included 50 conditionally healthy people living in Irkutsk who had negative PCR results for SARS-CoV-2 RNA presence.Specific IgG and IgM antibodies to SARS-CoV-2 were detected in blood serum by enzyme-linked immunosorbent assay (ELISA) using test systems “ELISA anti-SARS-CoV-2 IgG” (FBUN SSC PMB, Obolensk, Russian Federation), “SARS-CoV-2-IgG-IFA-BEST” and “SARS-CoV-2-IgM-IFA-BEST” (Vector-Best, Novosibirsk, Russian Federation).Results. The results of a study of the humoral immunity of patients with asymptomatic and clinical forms of COVID-19 are presented. The data indicate the production of specific IgG in the blood serum of people in 2–3 weeks after SARSCov-2 infection and reaching its maximum level on the 20–21st day. The seroconversion rate was 94.9 %. It was shown that the geometric mean titer of antibodies in asymptomatic and mild forms of coronavirus infection did not differ statistically and amounted to 1:512 and 1:632, respectively. Higher titers of antibodies (1:1600) were detected in the moderate form.Conclusion. The research results can serve as a basis for studying the dynamics of changes in the indicators of the humoral immune response in patients with COVID-19 and for clarifying the duration of their post- infectious immunity in order to predict the development of the epidemic situation and to ensure the planning of specific prevention. |
| first_indexed | 2024-03-08T12:16:57Z |
| format | Article |
| id | doaj.art-67b0c32d84344077850233a511edb718 |
| institution | Directory Open Access Journal |
| issn | 2541-9420 2587-9596 |
| language | Russian |
| last_indexed | 2024-04-24T17:17:05Z |
| publishDate | 2020-11-01 |
| publisher | Scientific Сentre for Family Health and Human Reproduction Problems |
| record_format | Article |
| series | Acta Biomedica Scientifica |
| spelling | doaj.art-67b0c32d84344077850233a511edb7182024-03-28T07:49:23ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962020-11-0155263010.29413/ABS.2020-5.5.32057Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 FormsS. V. Balakhonov0V. I. Dubrovina1M. V. Chesnokova2V. V. Voitkova3A. B. Pyatidesyatnikova4D. D. Bryukhova5N. O. Kiseleva6K. M. Korytov7T. G. Kuznetsova8Zh. V. Markevich9Irkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorIrkutsk Antiplague Research Institute of Siberia and Far East of RospotrebnadzorBodaybo District HospitalBodaybo District HospitalBackground. Currently, during the COVID-19 pandemic, one of the most pressing healthcare problems is to ensure the safety of the population of the Russian Federation. There is insufficient information on the duration and intensity of post-infectious immunity in relation to SARS-CoV-2, especially in case of inapparent (without clinical signs), mild or latent forms of infection.Materials and methods. The study involved 99 volunteers with a laboratory confirmed PCR diagnosis of COVID-19 who were residents of the Irkutsk Region and of other regions of the Russian Federation and arrived to work in Bodaybo on a rotational basis. Also the study included 50 conditionally healthy people living in Irkutsk who had negative PCR results for SARS-CoV-2 RNA presence.Specific IgG and IgM antibodies to SARS-CoV-2 were detected in blood serum by enzyme-linked immunosorbent assay (ELISA) using test systems “ELISA anti-SARS-CoV-2 IgG” (FBUN SSC PMB, Obolensk, Russian Federation), “SARS-CoV-2-IgG-IFA-BEST” and “SARS-CoV-2-IgM-IFA-BEST” (Vector-Best, Novosibirsk, Russian Federation).Results. The results of a study of the humoral immunity of patients with asymptomatic and clinical forms of COVID-19 are presented. The data indicate the production of specific IgG in the blood serum of people in 2–3 weeks after SARSCov-2 infection and reaching its maximum level on the 20–21st day. The seroconversion rate was 94.9 %. It was shown that the geometric mean titer of antibodies in asymptomatic and mild forms of coronavirus infection did not differ statistically and amounted to 1:512 and 1:632, respectively. Higher titers of antibodies (1:1600) were detected in the moderate form.Conclusion. The research results can serve as a basis for studying the dynamics of changes in the indicators of the humoral immune response in patients with COVID-19 and for clarifying the duration of their post- infectious immunity in order to predict the development of the epidemic situation and to ensure the planning of specific prevention.https://www.actabiomedica.ru/jour/article/view/2436humoral immunityspecific antibodiescovid-19sars-cov-2 |
| spellingShingle | S. V. Balakhonov V. I. Dubrovina M. V. Chesnokova V. V. Voitkova A. B. Pyatidesyatnikova D. D. Bryukhova N. O. Kiseleva K. M. Korytov T. G. Kuznetsova Zh. V. Markevich Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms Acta Biomedica Scientifica humoral immunity specific antibodies covid-19 sars-cov-2 |
| title | Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms |
| title_full | Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms |
| title_fullStr | Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms |
| title_full_unstemmed | Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms |
| title_short | Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms |
| title_sort | studying humoral immune response at mild and asymptomatic covid 19 forms |
| topic | humoral immunity specific antibodies covid-19 sars-cov-2 |
| url | https://www.actabiomedica.ru/jour/article/view/2436 |
| work_keys_str_mv | AT svbalakhonov studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT vidubrovina studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT mvchesnokova studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT vvvoitkova studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT abpyatidesyatnikova studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT ddbryukhova studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT nokiseleva studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT kmkorytov studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT tgkuznetsova studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms AT zhvmarkevich studyinghumoralimmuneresponseatmildandasymptomaticcovid19forms |